SARS-CoV-2 IgG(RBD) ELISA Market - Global Outlook and Forecast 2021-2027

March 2021 | 92 pages | ID: S3F6DB30F261EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of SARS-CoV-2 IgG(RBD) ELISA in Global, including the following market information:

Global SARS-CoV-2 IgG(RBD) ELISA Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global SARS-CoV-2 IgG(RBD) ELISA market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the SARS-CoV-2 IgG(RBD) ELISA companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global SARS-CoV-2 IgG(RBD) ELISA Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global SARS-CoV-2 IgG(RBD) ELISA Market Segment Percentages, By Type, 2020 (%)

• ELISA Sets
• ELISA Kits

China SARS-CoV-2 IgG(RBD) ELISA Market, By Application, 2016-2021, 2022-2027 ($ millions)

China SARS-CoV-2 IgG(RBD) ELISA Market Segment Percentages, By Application, 2020 (%)

• Hospital
• Clinic
• Disease control and prevention system

Global SARS-CoV-2 IgG(RBD) ELISA Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global SARS-CoV-2 IgG(RBD) ELISA Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total SARS-CoV-2 IgG(RBD) ELISA Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total SARS-CoV-2 IgG(RBD) ELISA Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• R&D Systems
• Thermo Fisher Scientific
• Ortho Clinical Diagnostics
• BD Biosciences
• ZEUS Scientific
• Bio-Rad Laboratories
• ALPCO
• Enzo Life Sciences
• BioM?rieux
• LOEWE Biochemica
• Shenzhen YHLO Biotech
• LG

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 SARS-CoV-2 IgG(RBD) ELISA Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global SARS-CoV-2 IgG(RBD) ELISA Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL SARS-COV-2 IGG(RBD) ELISA OVERALL MARKET SIZE

2.1 Global SARS-CoV-2 IgG(RBD) ELISA Market Size: 2021 VS 2027
2.2 Global SARS-CoV-2 IgG(RBD) ELISA Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top SARS-CoV-2 IgG(RBD) ELISA Players in Global Market
3.2 Top Global SARS-CoV-2 IgG(RBD) ELISA Companies Ranked by Revenue
3.3 Global SARS-CoV-2 IgG(RBD) ELISA Revenue by Companies
3.4 Top 3 and Top 5 SARS-CoV-2 IgG(RBD) ELISA Companies in Global Market, by Revenue in 2020
3.5 Global Companies SARS-CoV-2 IgG(RBD) ELISA Product Type
3.6 Tier 1, Tier 2 and Tier 3 SARS-CoV-2 IgG(RBD) ELISA Players in Global Market
  3.6.1 List of Global Tier 1 SARS-CoV-2 IgG(RBD) ELISA Companies
  3.6.2 List of Global Tier 2 and Tier 3 SARS-CoV-2 IgG(RBD) ELISA Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global SARS-CoV-2 IgG(RBD) ELISA Market Size Markets, 2021 & 2027
  4.1.2 ELISA Sets
  4.1.3 ELISA Kits
4.2 By Type - Global SARS-CoV-2 IgG(RBD) ELISA Revenue & Forecasts
  4.2.1 By Type - Global SARS-CoV-2 IgG(RBD) ELISA Revenue, 2016-2021
  4.2.2 By Type - Global SARS-CoV-2 IgG(RBD) ELISA Revenue, 2022-2027
  4.2.3 By Type - Global SARS-CoV-2 IgG(RBD) ELISA Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global SARS-CoV-2 IgG(RBD) ELISA Market Size, 2021 & 2027
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Disease control and prevention system
5.2 By Application - Global SARS-CoV-2 IgG(RBD) ELISA Revenue & Forecasts
  5.2.1 By Application - Global SARS-CoV-2 IgG(RBD) ELISA Revenue, 2016-2021
  5.2.2 By Application - Global SARS-CoV-2 IgG(RBD) ELISA Revenue, 2022-2027
  5.2.3 By Application - Global SARS-CoV-2 IgG(RBD) ELISA Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global SARS-CoV-2 IgG(RBD) ELISA Market Size, 2021 & 2027
6.2 By Region - Global SARS-CoV-2 IgG(RBD) ELISA Revenue & Forecasts
  6.2.1 By Region - Global SARS-CoV-2 IgG(RBD) ELISA Revenue, 2016-2021
  6.2.2 By Region - Global SARS-CoV-2 IgG(RBD) ELISA Revenue, 2022-2027
  6.2.3 By Region - Global SARS-CoV-2 IgG(RBD) ELISA Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America SARS-CoV-2 IgG(RBD) ELISA Revenue, 2016-2027
  6.3.2 US SARS-CoV-2 IgG(RBD) ELISA Market Size, 2016-2027
  6.3.3 Canada SARS-CoV-2 IgG(RBD) ELISA Market Size, 2016-2027
  6.3.4 Mexico SARS-CoV-2 IgG(RBD) ELISA Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe SARS-CoV-2 IgG(RBD) ELISA Revenue, 2016-2027
  6.4.2 Germany SARS-CoV-2 IgG(RBD) ELISA Market Size, 2016-2027
  6.4.3 France SARS-CoV-2 IgG(RBD) ELISA Market Size, 2016-2027
  6.4.4 U.K. SARS-CoV-2 IgG(RBD) ELISA Market Size, 2016-2027
  6.4.5 Italy SARS-CoV-2 IgG(RBD) ELISA Market Size, 2016-2027
  6.4.6 Russia SARS-CoV-2 IgG(RBD) ELISA Market Size, 2016-2027
  6.4.7 Nordic Countries SARS-CoV-2 IgG(RBD) ELISA Market Size, 2016-2027
  6.4.8 Benelux SARS-CoV-2 IgG(RBD) ELISA Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia SARS-CoV-2 IgG(RBD) ELISA Revenue, 2016-2027
  6.5.2 China SARS-CoV-2 IgG(RBD) ELISA Market Size, 2016-2027
  6.5.3 Japan SARS-CoV-2 IgG(RBD) ELISA Market Size, 2016-2027
  6.5.4 South Korea SARS-CoV-2 IgG(RBD) ELISA Market Size, 2016-2027
  6.5.5 Southeast Asia SARS-CoV-2 IgG(RBD) ELISA Market Size, 2016-2027
  6.5.6 India SARS-CoV-2 IgG(RBD) ELISA Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America SARS-CoV-2 IgG(RBD) ELISA Revenue, 2016-2027
  6.6.2 Brazil SARS-CoV-2 IgG(RBD) ELISA Market Size, 2016-2027
  6.6.3 Argentina SARS-CoV-2 IgG(RBD) ELISA Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Revenue, 2016-2027
  6.7.2 Turkey SARS-CoV-2 IgG(RBD) ELISA Market Size, 2016-2027
  6.7.3 Israel SARS-CoV-2 IgG(RBD) ELISA Market Size, 2016-2027
  6.7.4 Saudi Arabia SARS-CoV-2 IgG(RBD) ELISA Market Size, 2016-2027
  6.7.5 UAE SARS-CoV-2 IgG(RBD) ELISA Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 R&D Systems
  7.1.1 R&D Systems Corporate Summary
  7.1.2 R&D Systems Business Overview
  7.1.3 R&D Systems SARS-CoV-2 IgG(RBD) ELISA Major Product Offerings
  7.1.4 R&D Systems SARS-CoV-2 IgG(RBD) ELISA Revenue in Global (2016-2021)
  7.1.5 R&D Systems Key News
7.2 Thermo Fisher Scientific
  7.2.1 Thermo Fisher Scientific Corporate Summary
  7.2.2 Thermo Fisher Scientific Business Overview
  7.2.3 Thermo Fisher Scientific SARS-CoV-2 IgG(RBD) ELISA Major Product Offerings
  7.2.4 Thermo Fisher Scientific SARS-CoV-2 IgG(RBD) ELISA Revenue in Global (2016-2021)
  7.2.5 Thermo Fisher Scientific Key News
7.3 Ortho Clinical Diagnostics
  7.3.1 Ortho Clinical Diagnostics Corporate Summary
  7.3.2 Ortho Clinical Diagnostics Business Overview
  7.3.3 Ortho Clinical Diagnostics SARS-CoV-2 IgG(RBD) ELISA Major Product Offerings
  7.3.4 Ortho Clinical Diagnostics SARS-CoV-2 IgG(RBD) ELISA Revenue in Global (2016-2021)
  7.3.5 Ortho Clinical Diagnostics Key News
7.4 BD Biosciences
  7.4.1 BD Biosciences Corporate Summary
  7.4.2 BD Biosciences Business Overview
  7.4.3 BD Biosciences SARS-CoV-2 IgG(RBD) ELISA Major Product Offerings
  7.4.4 BD Biosciences SARS-CoV-2 IgG(RBD) ELISA Revenue in Global (2016-2021)
  7.4.5 BD Biosciences Key News
7.5 ZEUS Scientific
  7.5.1 ZEUS Scientific Corporate Summary
  7.5.2 ZEUS Scientific Business Overview
  7.5.3 ZEUS Scientific SARS-CoV-2 IgG(RBD) ELISA Major Product Offerings
  7.5.4 ZEUS Scientific SARS-CoV-2 IgG(RBD) ELISA Revenue in Global (2016-2021)
  7.5.5 ZEUS Scientific Key News
7.6 Bio-Rad Laboratories
  7.6.1 Bio-Rad Laboratories Corporate Summary
  7.6.2 Bio-Rad Laboratories Business Overview
  7.6.3 Bio-Rad Laboratories SARS-CoV-2 IgG(RBD) ELISA Major Product Offerings
  7.6.4 Bio-Rad Laboratories SARS-CoV-2 IgG(RBD) ELISA Revenue in Global (2016-2021)
  7.6.5 Bio-Rad Laboratories Key News
7.7 ALPCO
  7.7.1 ALPCO Corporate Summary
  7.7.2 ALPCO Business Overview
  7.7.3 ALPCO SARS-CoV-2 IgG(RBD) ELISA Major Product Offerings
  7.4.4 ALPCO SARS-CoV-2 IgG(RBD) ELISA Revenue in Global (2016-2021)
  7.7.5 ALPCO Key News
7.8 Enzo Life Sciences
  7.8.1 Enzo Life Sciences Corporate Summary
  7.8.2 Enzo Life Sciences Business Overview
  7.8.3 Enzo Life Sciences SARS-CoV-2 IgG(RBD) ELISA Major Product Offerings
  7.8.4 Enzo Life Sciences SARS-CoV-2 IgG(RBD) ELISA Revenue in Global (2016-2021)
  7.8.5 Enzo Life Sciences Key News
7.9 BioM?rieux
  7.9.1 BioM?rieux Corporate Summary
  7.9.2 BioM?rieux Business Overview
  7.9.3 BioM?rieux SARS-CoV-2 IgG(RBD) ELISA Major Product Offerings
  7.9.4 BioM?rieux SARS-CoV-2 IgG(RBD) ELISA Revenue in Global (2016-2021)
  7.9.5 BioM?rieux Key News
7.10 LOEWE Biochemica
  7.10.1 LOEWE Biochemica Corporate Summary
  7.10.2 LOEWE Biochemica Business Overview
  7.10.3 LOEWE Biochemica SARS-CoV-2 IgG(RBD) ELISA Major Product Offerings
  7.10.4 LOEWE Biochemica SARS-CoV-2 IgG(RBD) ELISA Revenue in Global (2016-2021)
  7.10.5 LOEWE Biochemica Key News
7.11 Shenzhen YHLO Biotech
  7.11.1 Shenzhen YHLO Biotech Corporate Summary
  7.11.2 Shenzhen YHLO Biotech Business Overview
  7.11.3 Shenzhen YHLO Biotech SARS-CoV-2 IgG(RBD) ELISA Major Product Offerings
  7.11.4 Shenzhen YHLO Biotech SARS-CoV-2 IgG(RBD) ELISA Revenue in Global (2016-2021)
  7.11.5 Shenzhen YHLO Biotech Key News
7.12 LG
  7.12.1 LG Corporate Summary
  7.12.2 LG Business Overview
  7.12.3 LG SARS-CoV-2 IgG(RBD) ELISA Major Product Offerings
  7.12.4 LG SARS-CoV-2 IgG(RBD) ELISA Revenue in Global (2016-2021)
  7.12.5 LG Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. SARS-CoV-2 IgG(RBD) ELISA Market Opportunities & Trends in Global Market
Table 2. SARS-CoV-2 IgG(RBD) ELISA Market Drivers in Global Market
Table 3. SARS-CoV-2 IgG(RBD) ELISA Market Restraints in Global Market
Table 4. Key Players of SARS-CoV-2 IgG(RBD) ELISA in Global Market
Table 5. Top SARS-CoV-2 IgG(RBD) ELISA Players in Global Market, Ranking by Revenue (2019)
Table 6. Global SARS-CoV-2 IgG(RBD) ELISA Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global SARS-CoV-2 IgG(RBD) ELISA Revenue Share by Companies, 2016-2021
Table 8. Global Companies SARS-CoV-2 IgG(RBD) ELISA Product Type
Table 9. List of Global Tier 1 SARS-CoV-2 IgG(RBD) ELISA Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 SARS-CoV-2 IgG(RBD) ELISA Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - SARS-CoV-2 IgG(RBD) ELISA Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - SARS-CoV-2 IgG(RBD) ELISA Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - SARS-CoV-2 IgG(RBD) ELISA Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - SARS-CoV-2 IgG(RBD) ELISA Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global SARS-CoV-2 IgG(RBD) ELISA Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global SARS-CoV-2 IgG(RBD) ELISA Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2022-2027
Table 30. R&D Systems Corporate Summary
Table 31. R&D Systems SARS-CoV-2 IgG(RBD) ELISA Product Offerings
Table 32. R&D Systems SARS-CoV-2 IgG(RBD) ELISA Revenue (US$, Mn), (2016-2021)
Table 33. Thermo Fisher Scientific Corporate Summary
Table 34. Thermo Fisher Scientific SARS-CoV-2 IgG(RBD) ELISA Product Offerings
Table 35. Thermo Fisher Scientific SARS-CoV-2 IgG(RBD) ELISA Revenue (US$, Mn), (2016-2021)
Table 36. Ortho Clinical Diagnostics Corporate Summary
Table 37. Ortho Clinical Diagnostics SARS-CoV-2 IgG(RBD) ELISA Product Offerings
Table 38. Ortho Clinical Diagnostics SARS-CoV-2 IgG(RBD) ELISA Revenue (US$, Mn), (2016-2021)
Table 39. BD Biosciences Corporate Summary
Table 40. BD Biosciences SARS-CoV-2 IgG(RBD) ELISA Product Offerings
Table 41. BD Biosciences SARS-CoV-2 IgG(RBD) ELISA Revenue (US$, Mn), (2016-2021)
Table 42. ZEUS Scientific Corporate Summary
Table 43. ZEUS Scientific SARS-CoV-2 IgG(RBD) ELISA Product Offerings
Table 44. ZEUS Scientific SARS-CoV-2 IgG(RBD) ELISA Revenue (US$, Mn), (2016-2021)
Table 45. Bio-Rad Laboratories Corporate Summary
Table 46. Bio-Rad Laboratories SARS-CoV-2 IgG(RBD) ELISA Product Offerings
Table 47. Bio-Rad Laboratories SARS-CoV-2 IgG(RBD) ELISA Revenue (US$, Mn), (2016-2021)
Table 48. ALPCO Corporate Summary
Table 49. ALPCO SARS-CoV-2 IgG(RBD) ELISA Product Offerings
Table 50. ALPCO SARS-CoV-2 IgG(RBD) ELISA Revenue (US$, Mn), (2016-2021)
Table 51. Enzo Life Sciences Corporate Summary
Table 52. Enzo Life Sciences SARS-CoV-2 IgG(RBD) ELISA Product Offerings
Table 53. Enzo Life Sciences SARS-CoV-2 IgG(RBD) ELISA Revenue (US$, Mn), (2016-2021)
Table 54. BioM?rieux Corporate Summary
Table 55. BioM?rieux SARS-CoV-2 IgG(RBD) ELISA Product Offerings
Table 56. BioM?rieux SARS-CoV-2 IgG(RBD) ELISA Revenue (US$, Mn), (2016-2021)
Table 57. LOEWE Biochemica Corporate Summary
Table 58. LOEWE Biochemica SARS-CoV-2 IgG(RBD) ELISA Product Offerings
Table 59. LOEWE Biochemica SARS-CoV-2 IgG(RBD) ELISA Revenue (US$, Mn), (2016-2021)
Table 60. Shenzhen YHLO Biotech Corporate Summary
Table 61. Shenzhen YHLO Biotech SARS-CoV-2 IgG(RBD) ELISA Product Offerings
Table 62. Shenzhen YHLO Biotech SARS-CoV-2 IgG(RBD) ELISA Revenue (US$, Mn), (2016-2021)
Table 63. LG Corporate Summary
Table 64. LG SARS-CoV-2 IgG(RBD) ELISA Product Offerings
Table 65. LG SARS-CoV-2 IgG(RBD) ELISA Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. SARS-CoV-2 IgG(RBD) ELISA Segment by Type
Figure 2. SARS-CoV-2 IgG(RBD) ELISA Segment by Application
Figure 3. Global SARS-CoV-2 IgG(RBD) ELISA Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global SARS-CoV-2 IgG(RBD) ELISA Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global SARS-CoV-2 IgG(RBD) ELISA Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by SARS-CoV-2 IgG(RBD) ELISA Revenue in 2020
Figure 8. By Type - Global SARS-CoV-2 IgG(RBD) ELISA Revenue Market Share, 2016-2027
Figure 9. By Application - Global SARS-CoV-2 IgG(RBD) ELISA Revenue Market Share, 2016-2027
Figure 10. By Region - Global SARS-CoV-2 IgG(RBD) ELISA Revenue Market Share, 2016-2027
Figure 11. By Country - North America SARS-CoV-2 IgG(RBD) ELISA Revenue Market Share, 2016-2027
Figure 12. US SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2016-2027
Figure 13. Canada SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe SARS-CoV-2 IgG(RBD) ELISA Revenue Market Share, 2016-2027
Figure 16. Germany SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2016-2027
Figure 17. France SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2016-2027
Figure 19. Italy SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2016-2027
Figure 20. Russia SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia SARS-CoV-2 IgG(RBD) ELISA Revenue Market Share, 2016-2027
Figure 24. China SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2016-2027
Figure 25. Japan SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2016-2027
Figure 28. India SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America SARS-CoV-2 IgG(RBD) ELISA Revenue Market Share, 2016-2027
Figure 30. Brazil SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa SARS-CoV-2 IgG(RBD) ELISA Revenue Market Share, 2016-2027
Figure 33. Turkey SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2016-2027
Figure 34. Israel SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2016-2027
Figure 36. UAE SARS-CoV-2 IgG(RBD) ELISA Revenue, (US$, Mn), 2016-2027
Figure 37. R&D Systems SARS-CoV-2 IgG(RBD) ELISA Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Thermo Fisher Scientific SARS-CoV-2 IgG(RBD) ELISA Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Ortho Clinical Diagnostics SARS-CoV-2 IgG(RBD) ELISA Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. BD Biosciences SARS-CoV-2 IgG(RBD) ELISA Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. ZEUS Scientific SARS-CoV-2 IgG(RBD) ELISA Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Bio-Rad Laboratories SARS-CoV-2 IgG(RBD) ELISA Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. ALPCO SARS-CoV-2 IgG(RBD) ELISA Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Enzo Life Sciences SARS-CoV-2 IgG(RBD) ELISA Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. BioM?rieux SARS-CoV-2 IgG(RBD) ELISA Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. LOEWE Biochemica SARS-CoV-2 IgG(RBD) ELISA Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Shenzhen YHLO Biotech SARS-CoV-2 IgG(RBD) ELISA Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. LG SARS-CoV-2 IgG(RBD) ELISA Revenue Year Over Year Growth (US$, Mn) & (2016-2021)